세계의 소아 심혈관 중재시술 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 디바이스 유형별, 절차별, 지역별, 경쟁별(2020-2030년)

The Global Pediatric Interventional Cardiology Market was valued at USD 2.41 billion in 2024 and is forecast to experience significant growth, registering a CAGR of 6.72% through 2030. This market focuses on minimally invasive procedures for diagnosing and treating heart defects in children, offering safer alternatives to conventional open-heart surgery. Driven by technological advancements in imaging, catheterization, and device innovation, interventional cardiology is increasingly used to manage congenital and acquired heart conditions in pediatric populations. High prevalence rates of congenital heart defects (CHDs), particularly in developed nations such as the United States, underscore the urgent demand for pediatric cardiovascular care. Enhanced early detection techniques and long-term care approaches are playing a crucial role in advancing patient outcomes, contributing to the market's rapid growth and global expansion.

Key Market Drivers

Rising Incidence of Congenital Heart Diseases (CHD)

The increasing prevalence of congenital heart diseases (CHDs) is a major force driving the Global Pediatric Interventional Cardiology Market. These structural and functional heart abnormalities, present at birth, often necessitate early and specialized medical intervention. CHDs can range from minor defects to life-threatening conditions, requiring timely diagnosis and treatment. According to the CDC, CHDs affect nearly 1% of all newborns in the United States-around 40,000 infants annually. Among these, approximately 25% are diagnosed with critical heart defects that require surgical or interventional procedures within the first year of life. Technological advancements in fetal and postnatal diagnostics-such as echocardiography, ultrasound, and genetic screening-enable earlier and more accurate detection of CHDs, allowing for timely and effective treatment. This growing burden of CHD globally is accelerating the adoption of pediatric interventional cardiology solutions.

Key Market Challenges

Limited Access to Specialized Care

Access to specialized pediatric cardiac care remains a key challenge, particularly in underserved and low-income regions. Many healthcare facilities in these areas lack the necessary infrastructure, trained personnel, and diagnostic capabilities to provide early and effective interventional cardiac treatments for children. This gap limits the reach of life-saving procedures and contributes to delayed treatment and poorer outcomes in affected pediatric populations.

Key Market Trends

Transcatheter Valve Therapies

Transcatheter valve interventions are emerging as a transformative trend in pediatric cardiology. These minimally invasive procedures allow for the repair or replacement of heart valves without the need for open-heart surgery, significantly reducing recovery time and procedural risk. The adoption of transcatheter valve technologies reflects a broader shift toward less invasive cardiac interventions in children, improving both safety and clinical outcomes in complex cases.

Key Market Players

• Abbott Laboratories Inc
• Biotronik Inc
• Boston Scientific Corporation
• Canon Medical Systems Corp
• Cardinal Health Inc
• Cordis Corp
• Edwards Lifesciences LLC
• GE Healthcare Inc
• Medtronic Inc
• Siemens Healthineers AG

Report Scope:

In this report, the Global Pediatric Interventional Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Interventional Cardiology Market, By Device Type:

• Closure Devices
• Transcatheter Heart Valves
• Atherectomy Devices
• Catheters
• Balloons
• Stents
• Others

Pediatric Interventional Cardiology Market, By Procedure:

• Catheter-Based Valve Implantation
• Congenital Heart Defect Correction
• Angioplasty
• Coronary Thrombectomy
• Others

Pediatric Interventional Cardiology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Interventional Cardiology Market.

Available Customizations:

Global Pediatric Interventional Cardiology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Interventional Cardiology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 5.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Device Type
  • 5.3.2. By Procedure
  • 5.3.3. By Region

6. North America Pediatric Interventional Cardiology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 6.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pediatric Interventional Cardiology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Procedure
  • 6.3.2. Canada Pediatric Interventional Cardiology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Procedure
  • 6.3.3. Mexico Pediatric Interventional Cardiology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Procedure

7. Europe Pediatric Interventional Cardiology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 7.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pediatric Interventional Cardiology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Procedure
  • 7.3.2. United Kingdom Pediatric Interventional Cardiology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Procedure
  • 7.3.3. France Pediatric Interventional Cardiology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Procedure
  • 7.3.4. Italy Pediatric Interventional Cardiology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Procedure
  • 7.3.5. Spain Pediatric Interventional Cardiology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Procedure

8. Asia-Pacific Pediatric Interventional Cardiology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 8.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pediatric Interventional Cardiology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Procedure
  • 8.3.2. Japan Pediatric Interventional Cardiology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Procedure
  • 8.3.3. India Pediatric Interventional Cardiology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Procedure
  • 8.3.4. Australia Pediatric Interventional Cardiology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Procedure
  • 8.3.5. South Korea Pediatric Interventional Cardiology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Procedure

9. South America Pediatric Interventional Cardiology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 9.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pediatric Interventional Cardiology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Procedure
  • 9.3.2. Argentina Pediatric Interventional Cardiology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Procedure
  • 9.3.3. Colombia Pediatric Interventional Cardiology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Procedure

10. Middle East and Africa Pediatric Interventional Cardiology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 10.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pediatric Interventional Cardiology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Procedure
  • 10.3.2. Saudi Arabia Pediatric Interventional Cardiology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Procedure
  • 10.3.3. UAE Pediatric Interventional Cardiology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Procedure
  • 10.3.4. Kuwait Pediatric Interventional Cardiology Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Device Type
      • 10.3.4.2.2. By Procedure

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Biotronik Inc
• 14.3. Boston Scientific Corporation
• 14.4. Canon Medical Systems Corp
• 14.5. Cardinal Health Inc
• 14.6. Cordis Corp
• 14.7. Edwards Lifesciences LLC
• 14.8. GE Healthcare Inc
• 14.9. Medtronic Inc
• 14.10. Siemens Healthineers AG

15. Strategic Recommendations

16. About Us & Disclaimer